Clinical Trial

Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

Investigator
Complete title:
Prevention of Respiratory Viruses using Nozin in Stem Cell Transplant Recipients (PREV-NOSE Study)
Trial phase:
Phase I
Study ID:
NCT04060849
Local study ID:
RG1004525
Summary:
This phase I trial studies the side effects of Nozin in preventing respiratory viral infections in patients undergoing stem cell transplant. Nozin is a non-antibiotic, alcohol-based nasal sanitizer used in hospitals to prevent spread of bacterial infections and may also prevent community acquired respiratory virus infection in stem cell transplant recipients.
Trial keywords:
Central Nervous System (CNS), Hematopoietic Stem Cell Transplantation, Allogeneic, Neoplasms, Malignant
Enrollment status:
Recruiting
Trial eligibility
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Trial exclusions
Other exclusion criteria may apply.
Learn more

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Contact us
Seattle Cancer Care Alliance Intake Office
phone 1-800-606-7800
Toll-free